Interactive Transcript
0:00
Our next topic is recall
0:02
from screening mammography.
0:05
And we have to remember that about
0:07
10 percent of patients who undergo
0:10
screening mammography will be recalled.
0:13
And the types of findings that we look for
0:16
on screening mammograms include asymmetries,
0:19
masses, calcifications, architectural
0:22
distortion, and enlarged lymph nodes.
0:26
So, you know, we have to be prepared
0:29
on the diagnostic imaging service
0:31
to evaluate each type of finding.
0:35
So we'll start with asymmetry.
0:37
And according to the BI-RADS atlas,
0:39
there are four types of asymmetry.
0:42
Just using the word asymmetry
0:44
refers to a one-view finding.
0:48
So either on the CC or the MLO view, but not both.
0:51
A focal asymmetry is seen on two views.
0:55
A developing asymmetry is new or increased
0:58
compared to the previous examinations.
1:00
And then a global asymmetry refers
1:02
to a larger area, usually at
1:04
least a quadrant of breast tissue.
1:08
It's seen on two views,
1:09
and it's often a normal variant.
1:14
So, for the one-view asymmetry, we know that these
1:17
are, um, often related to superimposed normal
1:20
breast tissue, um, about 80 percent of the time
1:24
from work, uh, done by Ed Sickles back in the '90s.
1:29
And Sickles in a 1998 study found a
1:34
1.8% malignancy rate,
1:35
and that was, uh, with 2D mammography.
1:38
A more recent study published
1:40
this year by Gong et al.
1:42
looked at tomosynthesis.
1:44
Recalls for one-view asymmetry
1:46
and found a 1.7% malignancy rate.
1:50
So it's interesting that, you know, many years
1:52
have passed and we've gone from 2D to 3D,
1:55
but the malignancy rate has stayed about the same.
1:57
So under 2% a developing
2:01
asymmetry is, is more concerning.
2:04
So this is a two-view asymmetry
2:06
that's new or increasing over time.
2:08
And there've been, uh, a few
2:10
different studies looking at this.
2:12
One of the seminal, uh, studies was
2:14
Liang and Sickles published in 2007.
2:18
This was looking at the malignancy rate
2:20
on 2D mammography, and they found a
2:22
12.8 percent malignancy rate on screening
2:26
mammograms recalled for developing asymmetry.
2:29
Um, Cheeseborough et al. in 2016.
2:30
56 00:02:32,659 --> 00:02:34,950 uh, showed a 15 percent malignancy
2:34
rate in cases found on 2D, and then
2:37
a more recent study by Liang et al.
2:40
published this year, 2022, found a 20
2:44
percent malignancy rate in cases found
2:46
on digital breast homosynthesis,
2:49
even among those with no ultrasound correlate.
2:52
So this is an important finding,
2:54
the developing asymmetry.
2:58
Our evaluation at Hopkins, we have
3:01
a slightly different approach for
3:03
asymmetry versus focal asymmetry.
3:05
So the, for the one-view finding, we usually
3:08
repeat the full CC or MLO view that showed the
3:11
finding because sometimes that alone eliminates
3:14
the problem, just a slightly different degree
3:17
of compression or slightly different positioning
3:20
of the tissue, um, can relieve that issue.
3:23
Um, we also do a spot compression view in the
3:26
projection that showed the finding and also a
3:28
full lateral view for focal asymmetry that's seen
3:32
on both views. We'll do spot compression in both
3:35
the CC and MLO views and a full lateral view.
3:39
At this point, we're about 90 to 95% tomosynthesis,
3:44
but sometimes, uh, we still have patients who
3:46
will have a 2D mammogram, either that's ordered
3:49
by their physician or, um, the patient prefers 2D.
3:53
So if the screening mammogram was 2D, then we will
3:56
consider starting with full tomosynthesis views.
3:59
Rather than doing those,
4:01
um, spot compression views.
4:03
And then ultrasound will be at
4:04
the radiologist's discretion.
4:08
So there are a lot of reasons for asymmetry.
4:10
Um, it could be superimposed normal
4:13
breast tissue, and frequently the
4:14
one-view asymmetries are just that.
4:17
Um, it could be related to a
4:18
variation of position or compression.
4:21
Um, often we'll see asymmetries, um,
4:24
occurring in the setting of hormonal change.
4:27
That, um, the patient has maybe gone
4:31
through menopause or begins to, um,
4:33
taking hormone replacement therapy or
4:35
has some other hormonal, uh, variation.
4:39
It could be related to a weight change.
4:41
The patient has lost weight or gained weight
4:43
and tissue becomes more or less, um, prominent
4:46
appearing on the mammogram related to that.
4:49
Um, and then there are actual lesions in the
4:51
breast that can cause, um, the finding of
4:55
asymmetry, including cysts, benign masses.
4:58
Um, frequently we'll see this entity called
5:01
PASH, pseudoangiomatous stromal hyperplasia, um,
5:05
fibrosis, breast cancer, either ductal carcinoma
5:08
in situ or invasive breast cancers, and lymphoma.
© 2024 Medality. All Rights Reserved.